U.S. Building Stock News

In February 2026, Gentherm reported fourth‑quarter 2025 earnings showing net income falling to US$2.99 million from US$15.32 million a year earlier, while quarterly revenue of about US$382.79 million came in ahead of expectations. Alongside weaker profitability, Gentherm issued product revenue guidance of US$1.5 billion to US$1.6 billion for 2026 and US$1.7 billion for 2027, highlighting its ambition to grow beyond automotive into medical and other precision thermal applications. We’ll now...

Twist Bioscience, NasdaqGS:TWST, has entered a co exclusive licensing agreement with Invenra Inc. for Invenra's B Body bispecific antibody platform. The deal expands Twist's antibody discovery services and includes an equity investment and licensing terms that share economics between the two companies. This move adds bispecific antibody capabilities to Twist's existing biologics discovery tools, broadening the range of programs it can support for biotech and pharma customers. Twist...

If you are wondering whether Danaos is still good value after its recent run, you are in the right place. This article focuses squarely on what you are paying for each dollar of the business. The stock last closed at US$111.57, with returns of 4.0% over 7 days, 10.8% over 30 days, 17.1% year to date, 41.5% over 1 year and 116.4% over 3 years. These figures naturally raise questions about how much upside or risk is now priced in. Recent coverage of Danaos has highlighted its role in the...

If you are wondering whether Regal Rexnord’s current share price really reflects what the business is worth, you are not alone. This article is built to help you assess that question clearly. With the stock at US$223.69 and returns of 2.1% over 7 days, 43.3% over 30 days, 53.1% year to date and 69.7% over 1 year, many investors are asking what is already priced in and what might still be on the table in terms of risk and reward. These moves sit against a backdrop where Regal Rexnord...

Analysts are flagging anticipated revenue declines for Fortive, citing softer demand and slower organic growth expectations. This shift in sentiment follows previously solid quarterly results and points to a possible inflection in the company’s operational outlook. The change comes as investors reassess Fortive’s near term growth profile beyond recent share price moves. For investors watching Fortive, ticker NYSE:FTV, the backdrop is a mix of steady share performance and growing questions...

Array Digital Infrastructure (NYSE:AD) has completed a transformation by selling its wireless operations and related spectrum assets. The company transferred spectrum holdings to major carriers, including T-Mobile and AT&T, and repositioned itself as a focused tower operator. Array Digital Infrastructure secured new long term Master License Agreements with top telecom companies for tower usage. The company distributed special dividends and outlined plans to invest further in its...

SI-BONE (SIBN) has wrapped up FY 2025 with Q4 revenue of about US$56.4 million and a basic EPS loss of US$0.04, alongside a trailing twelve month revenue base of roughly US$200.9 million and a TTM EPS loss of US$0.44. Over the past six quarters, revenue has moved from US$40.3 million in Q3 2024 to US$56.4 million in Q4 2025. Over the same period, quarterly basic EPS has ranged from a loss of US$0.16 in Q3 2024 to a loss of US$0.04 in the latest quarter, presenting a picture of expanding scale...

Dillard's (DDS) closed out FY 2026 with fourth quarter revenue of US$1,989.4 million and basic EPS of US$13.06, alongside net income of US$203.7 million. Earlier quarters showed revenue between US$1,490.97 million and US$1,546.97 million and EPS ranging from US$4.66 to US$10.39. Over the past year, the company reported trailing twelve month revenue of US$6.6 billion with basic EPS of US$36.32 and net income of US$570.2 million. These figures may prompt investors to focus closely on how...

Constellation Energy (CEG) has wrapped up FY 2025 with Q4 revenue of US$6.1b, Basic EPS of US$1.38 and net income of US$432m, putting a concrete set of numbers behind the recent share price of US$312.64. The company has seen quarterly revenue range between US$6.1b and US$6.8b across FY 2025, while Basic EPS moved from US$0.38 in Q1 to US$2.97 in Q3 before landing at US$1.38 in Q4, giving investors a clear view of how profit per share has shifted through the year. With trailing 12 month net...

Bank of Hawaii (NYSE:BOH) has announced that its CEO plans to retire at the end of March 2026. A board member recently executed a substantial sale of Bank of Hawaii shares. These leadership and ownership changes come as the stock last closed at $76.83. For investors watching Bank of Hawaii, the combination of a planned CEO retirement and a large board member share sale puts the focus squarely on governance and continuity. NYSE:BOH last closed at $76.83, with the stock showing returns of...

Vaxcyte (NasdaqGS:PCVX) has launched a comprehensive Phase 3 adult clinical program for its VAX-31 pneumococcal conjugate vaccine. The company has completed enrollment in a Phase 2 study of VAX-31 in infants. Vaxcyte is preparing to advance a separate vaccine candidate targeting Group A Streptococcus. These moves follow FDA alignment and an expanded Breakthrough Therapy designation for VAX-31. Vaxcyte, trading at about $61.35, is moving into a more mature stage of its pipeline, with VAX-31...

Oncolytics Biotech (ONCY) has attracted fresh attention after a recent move in its share price, with the stock closing at US$1.13 and showing mixed return patterns across the past year and over multiple years. See our latest analysis for Oncolytics Biotech. The recent 6.6% 1 day share price return and 10.8% 7 day share price return suggest short term momentum is building around Oncolytics Biotech, even as the 58.3% 1 year total shareholder return contrasts with weaker 3 and 5 year total...

Preferred Bank reclassified a sizable loan relationship from substandard to nonaccrual status following ongoing legal complications involving the borrower’s principals. The borrower is facing complex lawsuits that have contributed to cash flow pressures and payment issues on the loan. Management has indicated that, based on current expectations, the ultimate resolution of this credit is not expected to significantly affect 2026 earnings. For you as an investor following NasdaqGS:PFBC, this...

What the recent performance says about Farmers & Merchants Bank of Long Beach (FMBL) Farmers & Merchants Bank of Long Beach (FMBL) has quietly posted positive returns over several time frames, including the past week, month and past 3 months, alongside a 1 year total return above 50%. For a thinly traded regional bank founded in 1907 and focused on Southern California customers, these moves give you a reason to look more closely at how its current share price lines up with recent business...

Vistance Networks (NasdaqGS:VISN) has completed a major divestiture and rebranded its business focus. The company has closed a significant shelf registration and is shifting priorities toward debt elimination. Management has outlined plans to begin returning cash to shareholders through dividends. For investors watching Vistance Networks, these moves mark a clear reset in how the company is positioned and financed. The stock last closed at $17.95, with a 1-year return of 267.1% and a 3-year...

The Morning Bull - US Market Morning Update Wednesday, Feb, 25 2026 US stock futures are pointing slightly higher this morning, with E-mini S&P 500 contracts up about 0.1% and Nasdaq-100 futures ahead by roughly 0.2%, as investors weigh stronger hiring against easier borrowing costs. Fresh figures from ADP show private employers adding around 12,750 jobs a week over the past month, the fastest pace since late November, which signals companies are still hiring and paychecks are still flowing...

If you are wondering whether Sinclair's current share price fairly reflects its underlying worth, you are not alone. Many investors are asking the same question as the stock trades around US$14.06. The share price has seen mixed returns, with a 6.0% decline over the last 7 days and a 6.6% decline over 30 days, along with a 2.9% gain over 1 year and a 6.3% gain over 3 years, while the 5 year return sits at a 46.3% decline. Recent headlines around Sinclair have focused on its position in the...

Apple Hospitality REIT (NYSE:APLE) announced the resignation of Board member Kristian Gathright after seven years of service. During 2025, the company shifted 13 Marriott managed hotels to third party franchises and completed the sale of seven hotels. Apple Hospitality REIT also initiated share repurchases and continued investing in property development during 2025. Apple Hospitality REIT, trading at $12.15, has mixed longer term share performance, with a 5 year return of 13.3%, a 1 year...

If you are trying to work out whether OneStream is attractively priced or not, this article will walk through what its current valuation might be telling you. With the share price at US$23.48 and returns of 0.4% over 7 days, a 0.6% decline over 30 days and 32.5% year to date, OneStream has caught the eye of investors who are watching how sentiment could be shifting. Recent coverage has focused on OneStream as part of the broader conversation around software names, which helps explain why...

Enova International (NYSE:ENVA) announces an agreement to acquire Grasshopper Bancorp, Inc. The transaction adds a digital bank platform to Enova's existing fintech and online lending operations. The deal is expected to expand Enova's reach with small business and digitally focused customers. For investors, this move connects Enova International's consumer and small business lending focus with a full digital banking platform at Grasshopper Bancorp, Inc. NYSE:ENVA is already rooted in online...

FDA milestones put Larimar Therapeutics (LRMR) and nomlabofusp in sharper focus Larimar Therapeutics (LRMR) is back on investors’ radar after the FDA granted Breakthrough Therapy Designation to its Friedreich's ataxia candidate nomlabofusp and signaled openness to a surrogate endpoint supporting a potential accelerated approval filing. See our latest analysis for Larimar Therapeutics. The FDA update has arrived alongside a sharp pickup in momentum, with a 1 day share price return of 31.32%...

If you are wondering whether Veracyte shares are attractively priced right now, you are not alone. This article is built to help you think clearly about what you are paying for. The stock closed at US$35.69, with returns of a 0.9% decline over 7 days, a 15.6% decline over 30 days, a 15.8% decline year to date and a 6.7% decline over 1 year, while the 3 year return sits at 45.0% and the 5 year return at a 42.6% decline. Recent news coverage has focused on Veracyte's position in genomic...

In February 2026, Clean Energy Fuels reported fourth-quarter 2025 results showing revenue of US$112.32 million and a wider net loss of US$43.00 million, alongside guidance for a 2026 net loss attributable to the company of US$71.00 million to US$66.00 million, excluding unrealized contract impacts and estimated US$47.00 million of Amazon warrant charges. The company also flagged that swings in diesel and natural gas markets, plus variations in Amazon warrant vesting, could materially alter...

Lindsay (NYSE:LNN) has introduced two new safety products, the Road Runner Truck-Mounted Attenuator and the AlphaGuard Channelizing Device. The products expand the company’s roadway and work zone safety lineup, targeting construction and traffic management applications. Both launches focus on work zone protection, operational efficiency, and evolving infrastructure management needs. Lindsay, trading at $135.74, is building on its position in roadway and infrastructure safety with these new...